EQS-News: SynBiotic SE / Key word (s): Miscellaneous In full bloom: WEECO Pharma boosts SYNBIOTIC's sales 14.11.2024 / 13:30 CET/CEST The issuer is solely responsible for the content of this ...
YORVIPATH launching in U.S. with product availability expected mid-January 2025; ex-U.S. YORVIPATH revenue of €8.5 million in Q3– TransCon CNP ...
Hosted on MSN14h
Brookline Capital Downgrades Syros Pharmaceuticals (SYRS)Avidity Partners Management holds 1,674K shares representing 6.24% ownership of the company. No change in the last quarter.
Hosted on MSN14h
TD Cowen Downgrades Syros Pharmaceuticals (SYRS)Avidity Partners Management holds 1,674K shares representing 6.24% ownership of the company. No change in the last quarter.
VICTORIA, BC, Nov. 14, 2024 /PRNewswire/ - Eupraxia Pharmaceuticals Inc. (Eupraxia or the Company) (TSX: EPRX) (NASDAQ: EPRX ...
President Biden and Vice President Kamala Harris pretended to be anti-pharma but have taken over $10 million combined from ...
From drug pricing to reforming the drug regulatory process, Trump’s re-election has plenty of implications for the pharma ...
I have spent my career fighting for the hardworking people of our state—especially those who need our support the most.
Pharmaceutical companies can benefit from the FDA Fast Track and Accelerated Approval ... DSI provides regulatory, technical, ...
Adults with hypoparathyroidism treated with TransCon PTH in the phase 3 PaTHway open-label trial extension demonstrated ...
NTU Singapore is introducing two new undergraduate degree programmes in robotics and advanced chemical and pharmaceutical manufacturing in August ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback